ID   GBM2
AC   CVCL_DG58
SY   GBM 2
DR   cancercelllines; CVCL_DG58
DR   GEO; GSM1026856
DR   Progenetix; CVCL_DG58
DR   Wikidata; Q54835471
RX   PubMed=19147502;
RX   PubMed=23468990;
CC   Group: Cancer stem cell line.
CC   Omics: Array-based CGH.
CC   Omics: DNA methylation analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 7
//
RX   PubMed=19147502; DOI=10.1074/jbc.M807111200;
RA   Griffero F., Daga A., Marubbi D., Capra M.C., Melotti A.,
RA   Pattarozzi A., Gatti M., Bajetto A., Porcile C., Barbieri F.,
RA   Favoni R.E., Lo Casto M., Zona G., Spaziante R., Florio T., Corte G.;
RT   "Different response of human glioma tumor-initiating cells to
RT   epidermal growth factor receptor kinase inhibitors.";
RL   J. Biol. Chem. 284:7138-7148(2009).
//
RX   PubMed=23468990; DOI=10.1371/journal.pone.0057462;
RA   Baronchelli S., Bentivegna A., Redaelli S., Riva G., Butta V.,
RA   Paoletta L., Isimbaldi G., Miozzo M., Tabano S., Daga A., Marubbi D.,
RA   Cattaneo M., Biunno I., Dalpra L.;
RT   "Delineating the cytogenomic and epigenomic landscapes of glioma stem
RT   cell lines.";
RL   PLoS ONE 8:E57462-E57462(2013).
//